Drug - Prolia (denosumab) [Amgen]
Therapeutic area - Osteoporosis
Only healthcare professionals may administer Prolia. Bill using professional claim code J0897 (buy and bill).
Patients must meet the following three criteria:
One of the following:
- Patient is a postmenopausal woman with diagnosis of osteoporosis and at high risk for fracture
- Patient is a man at high risk for fracture and receiving androgen deprivation therapy for nonmetastatic prostate cancer
- Patient is a woman at high risk for fracture and receiving adjuvant aromatase inhibitor therapy for breast cancer
Patient has tried and failed 2 of the following drugs to increase bone mass: alendronate, calcitonin (Miacalcin), ibandronate (IV or oral), raloxifene, risedronate, or zoledronic acid.
Patient is currently taking calcium 1000 mg plus 400 IU of vitamin D daily.
MHCP Provider Call Center 651-431-2700 or 800-366-5411